BioSpace News Archive

Kite Pharma

At Kite, a Gilead Company, our singular focus is cell therapy to treat and cure cancer. Our goal is to bring the promise of cell therapy to as many eligible patients as possible who may benefit.
BridgeBio LLC

BridgeBio finds, develops, and delivers breakthrough medicines for genetic diseases.
Nitto BioPharma Inc.

Nitto BioPharma Inc. offers unique drug and nucleic acid (siRNA, miRNA, mRNA, etc) delivery solutions by designing novel biodegradable delivery vehicles with the combined ability to target specific cells and efficiently deliver a therapeutic moiety to the cells.
RareCyte

RareCyte is an innovative precision biology company that has developed technologies and end-to-end integrated platforms enabling advances in oncology, immuno-oncology, maternal-fetal health, and cell and gene therapy.
Travere Therapeutics

Travere Therapeutics is determined to bring life-changing treatments, support, and hope to people with rare disease.
23andMe

23andMe, headquartered in Sunnyvale, CA, is a leading consumer genetics and research company. Founded in 2006, the company’s mission is to help people access, understand, and benefit from the human genome.
Vaxcyte, Inc.

Vaxcyte is a vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. The Company is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases.
Tioma Therapeutics

renamed as Arch Oncology
Annexon, Inc.

Annexon is a clinical-stage biopharmaceutical company developing a new class of complement medicines for patients with classical complement-mediated autoimmune, neurodegenerative, and ophthalmic disorders of the body, brain, and eye.
BlueRock Therapeutics

BlueRock Therapeutics is a leading engineered cell therapy company with a mission to develop regenerative medicines for intractable diseases.